Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RArN9eiC9vXH0ngmhLjx8aDARGrpmNT5d2mOhcRbq1yrs#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- association type Statement assertion.
- cohort label "Adults" assertion.
- association label "Antipsychotics have been found to reduce BPD symptoms including aripiprazole (mean daily dose: 15 mg); ziprasidone (mean daily dose: 20 to 80 mg), olanzapine (mean daily dose: 5 to 9 mg, daily dose range 5 to 20 mg), haloperidol (mean daily dose 5 mg, daily dose range 4 to 16 mg), Quetiapine XL (at a daily dose of 150 mg). The empirically use of antipsychotics in patients with BPD are considered as off-label use." assertion.
- association subject DB00246 assertion.
- association predicate treats assertion.
- association object MONDO_0001156 assertion.
- association has_population_context cohort assertion.
- association relation OffLabelIndication assertion.
- cohort category Cohort assertion.
- DB00246 category Drug assertion.
- MONDO_0001156 category Disease assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association publications 28825781 assertion.
- association provided_by NeuroDKG assertion.